临床试验

CnF-DBS for Levodopa-Resistant FOG

NCT：NCT07781696 · NOT_YET_RECRUITING

NCT编号NCT07781696

状态NOT_YET_RECRUITING

SponsorIahn Cajigas (OTHER)

First posted2026-08-24

Last updated2026-08-24

简要摘要

The purpose of this trial is to study the safety, practicality, and effectiveness of deep brain stimulation (DBS) therapy in a brain region called the cuneiform nucleus (CnF) to treat disabling freezing of gait (FOG) in patients with Parkinson's disease (PD) when standard treatments are no longer effective. The study uses either the Medtronic's Percept™ PC or RC systems for DBS therapy. Please note that although the Medtronic systems are FDA-approved for other diseases, they have not been approved for the treatment of FOG in PD and their use for stimulation of the CnF target is experimental.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。